In industrial MSC manufacturing, the real challenge is often not freezing itself, but the waiting before it. Between cell harvest, counting, resuspension, aliquoting, and freezing preparation, cells m...
Following our previous post on extended 4°C holding, we also looked at what happens after thawing. In many MSC workflows, cells do not move directly from thawing to the next step. They may need to w...
In CAR-NK cryopreservation, viability alone is not enough. Functional retention after thaw is what really matters. We recently reviewed a CAR-NK cryopreservation validation case with CS-AT-D2, our cr...
Cryopreservation is not unique to iMSC — it is a shared challenge across almost all cell therapy workflows.But for off-the-shelf iMSC development, this step becomes especially important. Why? Because...
In Cell & Gene Therapy (CGT), long-term T cell stability directly affects process robustness, batch consistency, and downstream efficacy.CS-DX-N2, a DMSO-free cryopreservation medium from CellStor...
